论文部分内容阅读
目的探讨何种方案治疗支原体肺炎更有效、更经济。方法将87例患者分为3组:红霉素组、阿奇霉素组和联合用药组,分析其临床疗效。结果红霉素组发热缓解时间最短,阿奇霉素组和联合用药组肺部罗音消失时间较短,而联合用药组住院时间最短,所需费用最少(P<0.01)。结论无论从药代动力学还是从临床疗效来分析,红霉素和阿奇霉素联合治疗支原体肺炎更有效、经济和安全。
Objective To explore what kind of treatment of mycoplasma pneumonia is more effective and more economical. Methods Eighty-seven patients were divided into three groups: erythromycin group, azithromycin group and combination group. The clinical efficacy was analyzed. Results The eradication time of erythromycin group was the shortest, the disappearance time of pulmonary rales in azithromycin group and combination group was shorter, and the shortest hospitalization time in combination group was the least (P <0.01). Conclusion Whether combined with erythromycin and azithromycin in the treatment of mycoplasma pneumonia is more effective, economical and safe in terms of pharmacokinetics or clinical efficacy.